LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia

Pruimboom L, van Dam AC (2007) Chronic pain: a non-use disease. Med Hypotheses 68:506–511. doi: 10.1016/j.mehy.2006.08.036

Schmader KE, Baron R, Haanpaa ML, Mayer J, O’Connor AB, Rice AS, Stacey B (2010) Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc 85:S26–S32. doi: 10.4065/mcp.2009.0646

Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630–1635. doi: 10.1212/01.wnl.0000282763.29778.59

Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321. doi: 10.1016/j.diabres.2011.10.029

Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11:521–534. doi: 10.1016/S1474-4422(12)70065-0

Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM (2015) Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 6:432–444. doi: 10.4239/wjd.v6.i3.432

Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792:931–940. doi: 10.1016/j.bbadis.2008.11.005

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293. doi: 10.2337/dc10-1303

Davies M, Brophy S, Williams R, Taylor A (2006) The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 29:1518–1522. doi: 10.2337/dc05-2228

Tavakoli M, Malik RA (2008) Management of painful diabetic neuropathy. Expert Opin Pharmacother 9:2969–2978. doi: 10.1517/14656560802498149

Ponting CP, Belgard TG (2010) Transcribed dark matter: meaning or myth? Hum Mol Genet 19:R162–R168. doi: 10.1093/hmg/ddq362

Stein LD (2004) Human genome: end of the beginning. Nature 431:915–916. doi: 10.1038/431915a

Costa FF (2010) Non-coding RNAs: meet thy masters. Bioessays 32:599–608. doi: 10.1002/bies.200900112

Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. doi: 10.1016/j.cell.2009.01.002

Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467:415–419. doi: 10.1038/nature09351

Louro R, Smirnova AS, Verjovski-Almeida S (2009) Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 93:291–298. doi: 10.1016/j.ygeno.2008.11.009

Ponjavic J, Ponting CP, Lunter G (2007) Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 17:556–565. doi: 10.1101/gr.6036807

Batista PJ, Chang HY (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell 152:1298–1307. doi: 10.1016/j.cell.2013.02.012

Di Gesualdo F, Capaccioli S, Lulli M (2014) A pathophysiological view of the long non-coding RNA world. Oncotarget 5:10976–10996, doi:10.18632/oncotarget.2770

Qureshi IA, Mehler MF (2013) Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 10:632–646. doi: 10.1007/s13311-013-0199-0

Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361. doi: 10.1016/j.tcb.2011.04.001

Sauvageau M, Goff LA, Lodato S, Bonev B, Groff AF, Gerhardinger C, Sanchez-Gomez DB, Hacisuleyman E, Li E, Spence M, Liapis SC, Mallard W, Morse M, Swerdel MR, D’Ecclessis MF, Moore JC, Lai V, Gong G, Yancopoulos GD, Frendewey D, Kellis M, Hart RP, Valenzuela DM, Arlotta P, Rinn JL (2013) Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2:e1749. doi: 10.7554/eLife.01749

Guil S, Esteller M (2015) RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci 40:248–256. doi: 10.1016/j.tibs.2015.03.001

Hu W, Alvarez-Dominguez JR, Lodish HF (2012) Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep 13:971–983. doi: 10.1038/embor.2012.145

Kaikkonen MU, Lam MT, Glass CK (2011) Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90:430–440. doi: 10.1093/cvr/cvr097

Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629–641. doi: 10.1016/j.cell.2009.02.006

Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM, Chang HY (2013) A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife 2:e762. doi: 10.7554/eLife.00762

Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166. doi: 10.1146/annurev-biochem-051410-092902

Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58–86. doi: 10.1124/pr.58.1.5

Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659–797. doi: 10.1152/physrev.00043.2006

Burnstock G (2009) Purinergic receptors and pain. Curr Pharm Des 15:1717–1735. doi: 10.1124/pr.58.1.5

Burnstock G (2014) Purinergic signalling: from discovery to current developments. Exp Physiol 99:16–34. doi: 10.1113/expphysiol.2013.071951

Gao Y, Xu C, Liang S, Zhang A, Mu S, Wang Y, Wan F (2008) Effect of tetramethylpyrazine on primary afferent transmission mediated by P2X3 receptor in neuropathic pain states. Brain Res Bull 77:27–32. doi: 10.1016/j.brainresbull.2008.02.026

Gao Y, Liu H, Deng L, Zhu G, Xu C, Li G, Liu S, Xie J, Liu J, Kong F, Wu R, Li G, Liang S (2011) Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons. Brain Res Bull 84:406–413. doi: 10.1016/j.brainresbull.2011.01.017

Liang S, Xu C, Li G, Gao Y (2010) P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem Int 57:705–712. doi: 10.1016/j.neuint.2010.09.004

Burnstock G (2006) Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 110:433–454. doi: 10.1016/j.pharmthera.2005.08.013

Novakovic SD, Kassotakis LC, Oglesby IB, Smith JA, Eglen RM, Ford AP, Hunter JC (1999) Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 80:273–282. doi: 10.1016/S0304-3959(98)00225-5

Ueno S, Moriyama T, Honda K, Kamiya H, Sakurada T, Katsuragi T (2003) Involvement of P2X2 and P2X3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev Res 59:104–111. doi: 10.1002/ddr.10208

Zhang A, Gao Y, Zhong X, Xu C, Li G, Liu S, Lin J, Li X, Zhang Y, Liu H, Linag S (2010) Effect of sodium ferulate on the hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats. Brain Res 1313:215–221. doi: 10.1016/j.brainres.2009.11.067

Lin J, Li G, Den X, Xu C, Liu S, Gao Y, Liu H, Zhang J, Li X, Liang S (2010) VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X(2)(/)(3) receptor of primary sensory neurons. Brain Res Bull 83:284–291. doi: 10.1016/j.brainresbull.2010.08.002

Burnstock G, Novak I (2013) Purinergic signalling and diabetes. Purinergic Signal 9:307–324. doi: 10.1007/s11302-013-9359-2

Xu GY, Li G, Liu N, Huang LY (2011) Mechanisms underlying purinergic P2X3 receptor-mediated mechanical allodynia induced in diabetic rats. Mol Pain 7:60. doi: 10.1186/1744-8069-7-60

Hanani M, Blum E, Liu S, Peng L, Liang S (2014) Satellite glial cells in dorsal root ganglia are activated in streptozotocin-treated rodents. J Cell Mol Med 18:2367–2371. doi: 10.1111/jcmm.12406

Messinger RB, Naik AK, Jagodic MM, Nelson MT, Lee WY, Choe WJ, Orestes P, Latham JR, Todorovic SM, Jevtovic-Todorovic V (2009) In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145:184–195. doi: 10.1016/j.pain.2009.06.012

Xu H, Wu B, Jiang F, Xiong S, Zhang B, Li G, Liu S, Gao Y, Xu C, Tu G, Peng H, Liang S, Xiong H (2013) High fatty acids modulate P2X(7) expression and IL-6 release via the p38 MAPK pathway in PC12 cells. Brain Res Bull 94:63–70. doi: 10.1016/j.brainresbull.2013.02.002

Liu J, Li G, Peng H, Tu G, Kong F, Liu S, Gao Y, Xu H, Qiu S, Fan B, Zhu Q, Yu S, Zheng C, Wu B, Peng L, Song M, Wu Q, Li G, Liang S (2013) Sensory-sympathetic coupling in superior cervical ganglia after myocardial ischemic injury facilitates sympathoexcitatory action via P2X7 receptor. Purinergic Signal 9:463–479. doi: 10.1007/s11302-013-9367-2

Gunduz O, Oltulu C, Buldum D, Guven R, Ulugol A (2011) Anti-allodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin-induced diabetic rats. Neurosci Lett 491:23–25. doi: 10.1016/j.neulet.2010.12.063

Xu C, Xu W, Xu H, Xiong W, Gao Y, Li G, Liu S, Xie J, Tu G, Peng H, Qiu S, Liang S (2012) Role of puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons. Brain Res Bull 87:37–43. doi: 10.1016/j.brainresbull.2011.10.007

Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS (2007) Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8(Suppl 2):S50–S62. doi: 10.1111/j.1526-4637.2006.00179.x

Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28(Suppl- 1):8–14. doi: 10.1002/dmrr.2239

Galer BS, Gianas A, Jensen MP (2000) Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47:123–128. doi: 10.1016/S0168-8227(99)00112-6

Ziegler D (2009) Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 32(Suppl 2):S414–S419. doi: 10.2337/dc09-S350

Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, Spencer RH (2009) Peripheral mechanisms of pain and analgesia. Brain Res Rev 60:90–113. doi: 10.1016/j.brainresrev.2008.12.017

Burnstock G, Krugel U, Abbracchio MP, Illes P (2011) Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol 95:229–274. doi: 10.1016/j.pneurobio.2011.08.006

Seino D, Tokunaga A, Tachibana T, Yoshiya S, Dai Y, Obata K, Yamanaka H, Kobayashi K, Noguchi K (2006) The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain 123:193–203. doi: 10.1016/j.pain.2006.02.032